Bortezomib in Treating Patients With Advanced or Metastatic Transitional Cell Cancer of the Bladder, Renal Pelvis, or Ureter - Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00066352

Locations


United States, Illinois
	Cardinal Bernardin Cancer Center at Loyola University Medical Center
	Maywood, Illinois, United States, 60153-5500
	CCOP - Evanston
	Evanston, Illinois, United States, 60201
	Central Illinois Hematology Oncology Center
	Springfield, Illinois, United States, 62701
	University of Chicago Cancer Research Center
	Chicago, Illinois, United States, 60637-1470
	Ingalls Cancer Care Center at Ingalls Memorial Hospital
	Harvey, Illinois, United States, 60426
	Oncology/Hematology Associates of Central Illinois, P.C.
	Peoria, Illinois, United States, 61615-7828
	Decatur Memorial Hospital Cancer Care Institute
	Decatur, Illinois, United States, 62526

United States, Indiana
	CCOP - Northern Indiana CR Consortium
	South Bend, Indiana, United States, 46601
	Fort Wayne Medical Oncology and Hematology
	Fort Wayne, Indiana, United States, 46885-5099

United States, Michigan
	Oncology Care Associates, P.L.L.C.
	Saint Joseph, Michigan, United States, 49085

United States, Wisconsin
	Medical College of Wisconsin Cancer Center
	Milwaukee, Wisconsin, United States, 53226

Canada, Ontario
	Princess Margaret Hospital
	Toronto, Ontario, Canada, M5G 2M9
	Margaret and Charles Juravinski Cancer Centre
	Hamilton, Ontario, Canada, L8V 5C2
	Ottawa Hospital Regional Cancer Centre - General Campus
	Ottawa, Ontario, Canada, K1H 8L6
	London Regional Cancer Program at London Health Sciences Centre
	London, Ontario, Canada, N6A 4L6

Sponsors and Collaborators

Princess Margaret Hospital, Canada

National Cancer Institute (NCI)

Investigators


Study Chair:	Eric Winquist, MD	London Regional Cancer Program at London Health Sciences Centre